Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Follicular Lymphoma
Clinical trial register · Canada

Follicular Lymphoma Trials in Canada, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Canada and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6579 matching records held by the registry are in this view. Synced 20 Nov 2026, 03:20 UTC
6579
Studies in scope
all four open statuses
3493
Recruiting now
open to new participants
882
Lead sponsors
across recruiting studies
Top sites
Toronto 6 Montreal 5 Edmonton 4 Québec 3 Vancouver 3
Narrow the registerReset
Recruitment status
Phase
Target enrolment
to

Follicular Lymphoma trials in Canada

10 of 6579 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Canada
Start
Recruiting
Simulation-Free Single-Fraction Radiation Therapy for Indolent Lymphoma
NCT07945470Indolent B-Cell Non-Hodgkin Lymphoma, Marginal Zone Lymphoma, Follicular Lymphoma, Small Lymphocytic Lymphoma
University Health Network, Toronto
Not applicable
60
Toronto
2026-10-09
Recruiting
AbbVie
Observational
700
Edmonton, Moncton, St. John's, Greater Sudbury, Kingston
2025-03-28
Recruiting
IKS03 in Patients With Advanced B Cell Non-Hodgkin Lymphomas
NCT05365659B-cell Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma
Iksuda Therapeutics Ltd.
Phase 1
140
Montreal
2023-09-05
Active, closed
A Study of Zilovertamab Vedotin (MK-2140) as Monotherapy and in Combination in Participants With Aggressive and Indolent B-cell Malignancies (MK-2140-006)
NCT05458297Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Follicular Lymphoma, Richter Transformation Lymphoma
Merck Sharp & Dohme LLC
Phase 2
189
Vancouver, Moncton, Halifax, London, Toronto, Montreal, Regina
2022-07-21
Recruiting
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
NCT05006716B-cell Malignancy, Marginal Zone Lymphoma, Follicular Lymphoma, Non-Hodgkin Lymphoma
BeOne Medicines
Phase 1/2
689
Calgary, Edmonton, Vancouver, Toronto, Québec
2021-09-13
Active, closed
Incyte Corporation
Phase 3
654
Edmonton, Vancouver, Halifax, London, Montreal, Québec
2021-04-15
Active, closed
A Long-term Extension Study of PCI-32765 (Ibrutinib)
NCT01804686Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma
Janssen Research & Development, LLC
Phase 3
539
Montreal
2013-09-09
Rows per page Showing 1–10 of 10
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Canadian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 20 November 2026. https://priyalifescience.com/clinical-trials-canada/condition/follicular-lymphoma

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Canada and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,579 studies in total at the last sync on 20 Nov 2026, 03:20 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 10 of those studies listing the condition Follicular Lymphoma.

How many Follicular Lymphoma trials are recruiting in Canada?

5 of the 10 studies on this page are recruiting new participants as of the 20 Nov 2026, 03:20 UTC sync. A further 0 have not yet opened recruitment, 5 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Follicular Lymphoma), 10 studies
PhaseStudiesRecruitingShare
Phase 34140%
Phase 12120%
Not applicable1110%
Observational1110%
Phase 1/21110%
Phase 21010%

Most active sponsors

Lead sponsors with the most studies (Follicular Lymphoma)
Lead sponsorStudiesRecruiting
AbbVie21
BeOne Medicines11
Celgene11
Epizyme, Inc.10
Iksuda Therapeutics Ltd.11
Incyte Corporation10
Janssen Research & Development, LLC10
Merck Sharp & Dohme LLC10
University Health Network, Toronto11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.